Dental Care Clinics in Middletown, KY Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Oral Surgery Group Of Middletown, Pllc Dentist - Oral and Maxillofacial Surgery Medicare: Medicare Enrolled Practice Location: 134 Evergreen Rd, Middletown, KY 40243 Phone: 502-410-1702 |
Engilman Orthodontics Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 134 N Evergreen Rd, Suite 101, Middletown, KY 40243 Phone: 502-253-2201 Fax: 502-253-2202 |
Periodontic & Endodontic Services Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 11708 Main St, Middletown, KY 40243 Phone: 502-410-1702 |
Mortenson Family Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 11708 Main St, Middletown, KY 40243 Phone: 502-245-8627 Fax: 502-245-9395 |
News Archive
New analysis on global trends in medical imaging for cardiology applications
The promise of cost and clinical benefits are spurring the penetration of imaging modalities in cardiac applications. While demographics are favouring market growth, cardiac imaging device manufacturers will have to focus on innovative, patient-friendly products that promote greater safety and easier operability.
Initiating therapeutic anticoagulation benefits moderately ill COVID-19 patients, but not critically ill patients
A large clinical trial conducted worldwide shows that treating moderately ill hospitalized COVID-19 patients with a full-dose blood thinner reduced their need for organ support, such as mechanical ventilation, and improved their chances of leaving the hospital.
Stroma plays an important role in regulating spread of cancer cells
A major breakthrough by scientists at Queen's University Belfast could lead to more effective treatments for throat and cervical cancer.
BioLight seeks FDA IND approval for subconjunctival Latanoprost controlled release insert Phase I/IIa study
BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that ViSci, its wholly owned subsidiary, has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to conduct a Phase I/IIa clinical study with its subconjunctival Latanoprost controlled release insert for the treatment of glaucoma.
› Verified 7 days ago